2018 ASCO/CAP Her2 Testing Guidelines in Breast Cancer. Impact of the Updated Guidelines on Breast Carcinomas Originally Classified as Her2 Equivocal - A Retrospective Analysis

被引：0

作者：

Alzeer, Ali ^{[1
]}

Zeck, Jay ^{[1
]}

Laureano, Julio ^{[1
]}

Sidawy, Mary ^{[1
]}

机构：

[1] MedStar Georgetown Univ Hosp, Washington, DC USA

来源：

LABORATORY INVESTIGATION | 2019年 / 99卷

关键词：

D O I：

暂无

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

108

引用

页数：2

共 50 条

[21] Outcome of Repeat HER2 Testing After Initial Equivocal HER2 FISH Results Using 2013 ASCO/CAP Guidelines and Implications for Impact of Updated 2018 ASCO/CAP in Similar Cases [J].

Malone, V. ;

Walker, J. ;

Castriciano, G. ;

Maguire, A. .

JOURNAL OF PATHOLOGY, 2020, 250 :7-7

[22] Adding precision to 2018 ASCO/CAP HER2 testing guidelines in breast cancer with genomic profiling. [J].

Brufsky, Adam ;

Crozier, Jennifer A. ;

Chuba, Paul J. ;

Lee, Sung Ho ;

Menicucci, Andrea ;

Kling, Heather M. ;

Yoder, Erin ;

Audeh, William .

JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)

[23] ASCO/CAP 2018 breast cancer HER2 testing guidelines: summary of pertinent recommendations for practice in Australia [J].

Farshid, Gelareh ;

Bilous, Michael ;

Morey, Adrienne ;

Fox, Stephen ;

Lakhani, Sunil ;

Loi, Sherene ;

Bell, Richard ;

Spillane, Andrew .

PATHOLOGY, 2019, 51 (04) :345-348

[24] Impact of the 2013 ASCO/CAP HER2 revised guidelines on HER2 results in breast core biopsies with invasive breast carcinoma: a retrospective study [J].

Wynton B. Overcast ;

Jianying Zhang ;

Debra L. Zynger ;

Gary H. Tozbikian .

Virchows Archiv, 2016, 469 :203-212

[25] Impact of the 2013 ASCO/CAP HER2 revised guidelines on HER2 results in breast core biopsies with invasive breast carcinoma: a retrospective study [J].

Overcast, Wynton B. ;

Zhang, Jianying ;

Zynger, Debra L. ;

Tozbikian, Gary H. .

VIRCHOWS ARCHIV, 2016, 469 (02) :203-212

[26] Impact of repeat HER2 testing after initial equivocal HER2 FISH results using 2013 ASCO/CAP guidelines [J].

Xu, Fang-Ping ;

Wang, Kun ;

Xu, Jie ;

Chen, Jie ;

Zhang, Yi-Fang ;

Wu, Hong-Mei ;

Zhang, Ming-Hui ;

Long, Xiao-Xu ;

Luo, Xin-Lan ;

Zhang, Ke-Ping ;

Lin, Dan-Yi ;

Liu, Yan-Hui .

BREAST CANCER RESEARCH AND TREATMENT, 2017, 166 (03) :757-764

[27] Impact of repeat HER2 testing after initial equivocal HER2 FISH results using 2013 ASCO/CAP guidelines [J].

Fang-Ping Xu ;

Kun Wang ;

Jie Xu ;

Jie Chen ;

Yi-Fang Zhang ;

Hong-Mei Wu ;

Ming-Hui Zhang ;

Xiao-Xu Long ;

Xin-Lan Luo ;

Ke-Ping Zhang ;

Dan-Yi Lin ;

Yan-Hui Liu .

Breast Cancer Research and Treatment, 2017, 166 :757-764

[28] Changing pattern for HER2 positivity due to updated ASCO/CAP guidelines for HER2 testing and its impact. [J].

Shah, Mithun Vinod ;

Wiktor, Anne E. ;

Meyer, Reid G. ;

Tenner, Kathleen S. ;

Ballman, Karla V. ;

Ketterling, Rhett P. ;

Perez, Edith A. ;

Jenkins, Robert B. .

JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)

[29] The Impact of 2013 ASCO/CAP Guidelines on the Breast Cancer Her2/Neu FISH Results [J].

Zhang, Songlin ;

Wang, Xiaohong .

AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2018, 149 :S144-S144

[30] Impact of Recent 2018 ASCO-CAP HER2 Testing Guidelines on 2713 Breast Cancer Cases Treated According to 2013 ASCO-CAP HER2 Guidelines: Western Indian Tertiary Cancer Centre Experience [J].

Pai, T. ;

Ankolkar, M. ;

Shetty, O. ;

Gurav, M. ;

Dhanavade, S. ;

Kadam, V. ;

Tambe, S. ;

Patil, A. ;

Desai, S. ;

Shet, T. .

JOURNAL OF MOLECULAR DIAGNOSTICS, 2019, 21 (06) :1227-1227

← 1 2 3 4 5 →